Updated: Dec 18, 2020
Original title: Shenyang Smart Manufacturing! Ministry of Science and Technology of the PRC: Carrimycin is effective in the treatment of COVID-19
On March 26, the State Council Information Office of the PRC held a press conference where relevant officials from the Ministry of Foreign Affairs, the Ministry of Science and Technology, and the National Health Commission introduced about the international cooperation by China in the fight against COVID-19. It was disclosed at the press conference that the primary drug Carrimycin jointly developed by Shenyang Tonglian Group Co., Ltd. and the Institute of Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences is effective for the treatment of COVID-19.
The relevant clinical trials currently published show that Carrimycin can remove the Corona Virus from the human body promptly and effectively, improve clinical symptoms and lung inflammation significantly, and is extremely safe compared to other drugs. Especially for severe and critically ill patients, virus recovery and patients with failed antiviral therapy, it has obvious effect without obvious adverse reactions.
Editors in charge: Tang Long and Xiaoyuan